(Bloomberg) -- CVS Health Corp. is trying to buy stores and patient data from Rite Aid Corp., the beleaguered pharmacy chain that is going out of business after filing for bankruptcy a second time earlier this month. Most Read from Bloomberg As Coastline Erodes, One California City Considers ‘Retreat Now’ How a Highway Became San Francisco’s Newest Park Power-Hungry Data Centers Are Warming Homes in the Nordics Maryland’s Credit Rating Gets Downgraded as Governor Blames Trump NYC Commuters Brace for Chaos as NJ Transit Strike Looms CVS, which already owns the largest chain of retail pharmacies in the US, put in a bid for a significant number of stores in Washington, Oregon, and Idaho, as well as patient prescription information, Rite Aid Chief Executive Officer Matthew Schroeder told employees Thursday, according to a recording of the meeting reviewed by Bloomberg News. The additional stores would broaden CVS’s reach in a part of the country where it has a smaller presence per capita than in other regions. A CVS spokesperson declined to comment. Rite Aid didn’t immediately provide comment. Rite Aid has also received multiple bids on some of its pharmacy assets, such as patient data and inventory, from Walgreens Boots Alliance Inc., Albertsons Cos., Kroger Co., Giant Eagle Inc. and others, Schroeder said. The potential buyers are interested in continuing to employ Rite Aid workers, he said. “We are not going to emerge from bankruptcy,” Schroeder said to employees. “Once our assets are sold, Rite Aid will no longer exist.” Walgreens, Albertsons, Kroger, and Giant Eagle did not immediately provide comment. Bids will be presented to the bankruptcy court on May 21, Schroeder said. On June 6, the court will hold a hearing on Rite Aid’s plan for financing while it winds down the company. The drugstore chain fell victim to falling profits from prescriptions, government fines related to opioid pain medicines and a decline in consumer spending. The challenges have affected all the major retail pharmacies, which have closed more than a thousand of stores across the country in recent years. CVS, which had more than 9,000 locations at the end of last year, plans to close about 270 in 2025. Walgreens said it will shutter hundreds of stores this year. Rite Aid closed more than 850 stores during its first bankruptcy proceedings in 2023 and 2024, according to court filings. CVS said in February it expects a 5% drop in adjusted operating income from the division that houses its retail locations in 2025. It also makes money selling health insurance plans and pharmacy benefit management services. Story Continues Pharmacy chains such as CVS and Walgreens have been negotiating with pharmacy benefit managers to get paid more for prescriptions. --With assistance from Jonathan Randles. Most Read from Bloomberg Businessweek Cartoon Network’s Last Gasp DeepSeek’s ‘Tech Madman’ Founder Is Threatening US Dominance in AI Race Why Obesity Drugs Are Getting Cheaper — and Also More Expensive As Nuclear Power Makes a Comeback, South Korea Emerges a Winner Tariffs Won’t Reindustrialize America. Here’s What Will ©2025 Bloomberg L.P. View Comments
CVS Bids for Rite Aid Stores, Patient Files in Pacific Northwest
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...